Outcomes Flow Chart
Treatment Effectiveness
User reported effectiveness ratings Sertraline (Zoloft) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Menopause | 0% | 67% | 0% | 33% | 0% | 3 |
| Anxiety / Nervousness | 12% | 31% | 10% | 36% | 11% | 328 |
Side Effects
User-reported side effects of Sertraline (Zoloft)
| Side Effect | Percent of Reports Sertraline (Zoloft) |
|---|---|
| Nervousness | 30% |
| Diarrhea | 17% |
| Constipation | 15% |
| Dry Mouth | 37% |
| Changes in Sex Drive or Ability | 54% |
| Dizziness | 27% |
| Drowsiness | 37% |
| Excessive Sweating | 20% |
| Excessive Tiredness | 38% |
| Gas or Bloating | 22% |
| Loss of Appetite | 18% |
| Pain, Burning, or Tingling in the Hands or Feet | 12% |
| Sore Throat | 6% |
| Uncontrollable Shaking of a Part of the Body | 12% |
| Vomiting | 4% |
| Weight Changes | 41% |
| Headache | 27% |
| Nausea | 26% |
Outcomes
Below is the degree of change seen after Sertraline (Zoloft) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Sertraline (Zoloft) Info
| Property | Value |
|---|---|
| Variable Name | Sertraline (Zoloft) |
| Aggregation Method | SUM |
| Analysis Performed At | 2021-08-28 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 28.096774193548 |
| Mean | 0.516129 count |
| Median | 0.5 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 1 |
| Number of Measurements | 3 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 3 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0.089802651013387 |
| Unit | Count |
| User Variables | 2 |
| Variable Category | Treatments |
| Variable ID | 95238 |
| Variance | 0.016129032258065 |